The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies Posted on November 4, 2021January 10, 2022 by admin
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System Posted on June 29, 2021January 10, 2022 by admin
